Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2024

Open Access 01-12-2024 | Lipolysis | Research

Plasma adiponectin/leptin ratio associates with subcutaneous abdominal and omental adipose tissue characteristics in women

Authors: Eve-Julie Tremblay, André Tchernof, Mélissa Pelletier, Denis R. Joanisse, Pascale Mauriège

Published in: BMC Endocrine Disorders | Issue 1/2024

Login to get access

Abstract

Background

A better understanding of adipose tissue (AT) dysfunction, which includes morphological and functional changes such as adipocyte hypertrophy as well as impaired adipogenesis, lipid storage/mobilization, endocrine and inflammatory responses, is needed in the context of obesity. One dimension of AT dysfunction, secretory adiposopathy, often assessed as a low plasma adiponectin (A)/leptin (L) ratio, is commonly observed in obesity. The aim of this study was to examine markers of AT development and metabolism in 67 women of varying age and adiposity (age: 40-62 years; body mass index, BMI: 17-41 kg/m2) according to levels of adiponectinemia, leptinemia or the plasma A/L ratio.

Methods

Body composition, regional AT distribution and circulating adipokines were determined. Lipolysis was measured from glycerol release in subcutaneous abdominal (SCABD) and omental (OME) adipocytes under basal, isoproterenol-, forskolin (FSK)- and dibutyryl-cyclic AMP (DcAMP)-stimulated conditions. Adipogenesis (C/EBP-α/β/δ, PPAR-γ2 and SREBP-1c) and lipid metabolism (β2-ARs, HSL, FABP4, LPL and GLUT4) gene expression (RT-qPCR) was assessed in both fat depots. Participants in the upper versus lower tertile of adiponectin, leptin or the A/L ratio were compared.

Results

Basal lipolysis was similar between groups. Women with a low plasma A/L ratio were characterized by higher adiposity and larger SCABD and OME adipocytes (p<0.01) compared to those with a high ratio. In OME adipocytes, women in the low adiponectinemia tertile showed higher isoproterenol-stimulated lipolysis (0.01<p<0.05), while those in the high leptinemia tertile displayed increased lipolytic response to this agent (p<0.05). However, lipolysis stimulated by isoproterenol was enhanced in both compartments (0.01<p<0.05) in women with a low plasma A/L ratio. AT abundance of selected transcripts related to adipogenesis or lipid metabolism did not differ between women with or without secretory adiposopathy, except for lower GLUT4 mRNA levels in OME fat.

Conclusions

Secretory adiposopathy assessed as the plasma A/L ratio, more so than adiponectin or leptin levels alone, discriminates low and elevated lipolysis in OME and SCABD adipocytes despite similar AT expression of selected genes involved in lipid metabolism.
Appendix
Available only for authorised users
Literature
1.
go back to reference Piché ME, Poirier P, Lemieux I, Després JP. Overview of epidemiology and contribution of obesity and body Fat distribution to Cardiovascular Disease: an update. Prog Cardiovasc Dis. 2018;61(2):103–13.PubMedCrossRef Piché ME, Poirier P, Lemieux I, Després JP. Overview of epidemiology and contribution of obesity and body Fat distribution to Cardiovascular Disease: an update. Prog Cardiovasc Dis. 2018;61(2):103–13.PubMedCrossRef
2.
go back to reference Lee MJ, Wu Y, Fried SK. Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications. Mol Aspects Med. 2013;34(1):1–11.PubMedCrossRef Lee MJ, Wu Y, Fried SK. Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications. Mol Aspects Med. 2013;34(1):1–11.PubMedCrossRef
3.
go back to reference Tchernof A, Després JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93(1):359–404.PubMedCrossRef Tchernof A, Després JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93(1):359–404.PubMedCrossRef
4.
go back to reference Choe SS, Huh JY, Hwang IJ, Kim JI, Kim JB. Adipose tissue remodeling: its role in Energy Metabolism and Metabolic disorders. Front Endocrinol (Lausanne). 2016;7:30.PubMedCrossRef Choe SS, Huh JY, Hwang IJ, Kim JI, Kim JB. Adipose tissue remodeling: its role in Energy Metabolism and Metabolic disorders. Front Endocrinol (Lausanne). 2016;7:30.PubMedCrossRef
5.
go back to reference Grégoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev. 1998;78(3):783–809.PubMedCrossRef Grégoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev. 1998;78(3):783–809.PubMedCrossRef
6.
7.
go back to reference Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008;29(24):2959–71.PubMedCrossRef Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008;29(24):2959–71.PubMedCrossRef
8.
go back to reference Proenca AR, Sertie RA, Oliveira AC, Campana AB, Caminhotto RO, Chimin P, et al. New concepts in white adipose tissue physiology. Braz J Med Biol Res. 2014;47(3):192–205.PubMedPubMedCentralCrossRef Proenca AR, Sertie RA, Oliveira AC, Campana AB, Caminhotto RO, Chimin P, et al. New concepts in white adipose tissue physiology. Braz J Med Biol Res. 2014;47(3):192–205.PubMedPubMedCentralCrossRef
10.
11.
go back to reference Furuhashi M, Hotamisligil GS. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov. 2008;7(6):489–503.PubMedPubMedCentralCrossRef Furuhashi M, Hotamisligil GS. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov. 2008;7(6):489–503.PubMedPubMedCentralCrossRef
12.
go back to reference Frayn KN, Arner P, Yki-Jarvinen H. Fatty acid metabolism in adipose tissue, muscle and liver in health and disease. Essays Biochem. 2006;42:89–103.PubMedCrossRef Frayn KN, Arner P, Yki-Jarvinen H. Fatty acid metabolism in adipose tissue, muscle and liver in health and disease. Essays Biochem. 2006;42:89–103.PubMedCrossRef
13.
14.
go back to reference Arner P. Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab. 2005;19(4):471–82.PubMedCrossRef Arner P. Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab. 2005;19(4):471–82.PubMedCrossRef
16.
go back to reference Moreno-Indias I, Tinahones FJ. Impaired adipose tissue expandability and lipogenic capacities as ones of the main causes of metabolic disorders. J Diabetes Res. 2015;2015:970375.PubMedPubMedCentralCrossRef Moreno-Indias I, Tinahones FJ. Impaired adipose tissue expandability and lipogenic capacities as ones of the main causes of metabolic disorders. J Diabetes Res. 2015;2015:970375.PubMedPubMedCentralCrossRef
17.
go back to reference Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;316(2):129–39.PubMedCrossRef Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;316(2):129–39.PubMedCrossRef
18.
go back to reference Frühbeck G, Catalan V, Rodriguez A, Gomez-Ambrosi J. Adiponectin-leptin ratio: a promising index to estimate adipose tissue dysfunction. Relation with obesity-associated cardiometabolic risk. Adipocyte. 2018;7(1):57–62.PubMedCrossRef Frühbeck G, Catalan V, Rodriguez A, Gomez-Ambrosi J. Adiponectin-leptin ratio: a promising index to estimate adipose tissue dysfunction. Relation with obesity-associated cardiometabolic risk. Adipocyte. 2018;7(1):57–62.PubMedCrossRef
19.
go back to reference Blüher M, Mantzoros CS. From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century. Metabolism. 2015;64(1):131–45.PubMedCrossRef Blüher M, Mantzoros CS. From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century. Metabolism. 2015;64(1):131–45.PubMedCrossRef
20.
go back to reference Frühbeck G, Catalan V, Rodriguez A, Ramirez B, Becerril S, Salvador J, et al. Adiponectin-leptin ratio is a functional biomarker of adipose tissue inflammation. Nutrients. 2019;11(2):454.PubMedPubMedCentralCrossRef Frühbeck G, Catalan V, Rodriguez A, Ramirez B, Becerril S, Salvador J, et al. Adiponectin-leptin ratio is a functional biomarker of adipose tissue inflammation. Nutrients. 2019;11(2):454.PubMedPubMedCentralCrossRef
21.
go back to reference Harris RB. Direct and indirect effects of leptin on adipocyte metabolism. Biochim Biophys Acta. 2014;1842(3):414–23.PubMedCrossRef Harris RB. Direct and indirect effects of leptin on adipocyte metabolism. Biochim Biophys Acta. 2014;1842(3):414–23.PubMedCrossRef
22.
23.
go back to reference Michaud A, Boulet MM, Veilleux A, Noël S, Paris G, Tchernof A. Abdominal subcutaneous and omental adipocyte morphology and its relation to gene expression, lipolysis and adipocytokine levels in women. Metabolism. 2014;63(3):372–81.PubMedCrossRef Michaud A, Boulet MM, Veilleux A, Noël S, Paris G, Tchernof A. Abdominal subcutaneous and omental adipocyte morphology and its relation to gene expression, lipolysis and adipocytokine levels in women. Metabolism. 2014;63(3):372–81.PubMedCrossRef
24.
go back to reference Michaud A, Pelletier M, Noël S, Bouchard C, Tchernof A. Markers of macrophage infiltration and measures of lipolysis in human abdominal adipose tissues. Obes (Silver Spring). 2013;21(11):2342–9.CrossRef Michaud A, Pelletier M, Noël S, Bouchard C, Tchernof A. Markers of macrophage infiltration and measures of lipolysis in human abdominal adipose tissues. Obes (Silver Spring). 2013;21(11):2342–9.CrossRef
25.
go back to reference Deschênes D, Couture P, Dupont P, Tchernof A. Subdivision of the subcutaneous adipose tissue compartment and lipid-lipoprotein levels in women. Obes Res. 2003;11(3):469–76.PubMedCrossRef Deschênes D, Couture P, Dupont P, Tchernof A. Subdivision of the subcutaneous adipose tissue compartment and lipid-lipoprotein levels in women. Obes Res. 2003;11(3):469–76.PubMedCrossRef
26.
go back to reference Tchernof A, Desmeules A, Richard C, Laberge P, Daris M, Mailloux J, et al. Ovarian hormone status and abdominal visceral adipose tissue metabolism. J Clin Endocrinol Metab. 2004;89(7):3425–30.PubMedCrossRef Tchernof A, Desmeules A, Richard C, Laberge P, Daris M, Mailloux J, et al. Ovarian hormone status and abdominal visceral adipose tissue metabolism. J Clin Endocrinol Metab. 2004;89(7):3425–30.PubMedCrossRef
27.
go back to reference Tchernof A, Bélanger C, Morisset AS, Richard C, Mailloux J, Laberge P, et al. Regional differences in adipose tissue metabolism in women: minor effect of obesity and body fat distribution. Diabetes. 2006;55(5):1353–60.PubMedCrossRef Tchernof A, Bélanger C, Morisset AS, Richard C, Mailloux J, Laberge P, et al. Regional differences in adipose tissue metabolism in women: minor effect of obesity and body fat distribution. Diabetes. 2006;55(5):1353–60.PubMedCrossRef
28.
go back to reference Clément AA, Riesco E, Tessier S, Lacaille M, Pérusse F, Coté M, et al. The relationship between adiposopathy and glucose-insulin homeostasis is not affected by moderate-intensity aerobic training in healthy women with obesity. J Physiol Biochem. 2018;74(4):591–601.PubMedCrossRef Clément AA, Riesco E, Tessier S, Lacaille M, Pérusse F, Coté M, et al. The relationship between adiposopathy and glucose-insulin homeostasis is not affected by moderate-intensity aerobic training in healthy women with obesity. J Physiol Biochem. 2018;74(4):591–601.PubMedCrossRef
29.
go back to reference Tremblay EJ, Tchernof A, Pelletier M, Chabot N, Joanisse DR, Mauriege P. Contribution of markers of adiposopathy and adipose cell size in predicting insulin resistance in women of varying age and adiposity. Adipocyte. 2022;11(1):175–89.PubMedPubMedCentralCrossRef Tremblay EJ, Tchernof A, Pelletier M, Chabot N, Joanisse DR, Mauriege P. Contribution of markers of adiposopathy and adipose cell size in predicting insulin resistance in women of varying age and adiposity. Adipocyte. 2022;11(1):175–89.PubMedPubMedCentralCrossRef
30.
go back to reference Mauriège P, Marette A, Atgié C, Bouchard C, Thériault G, Bukowiecki LK, et al. Regional variation in adipose tissue metabolism of severely obese premenopausal women. J Lipid Res. 1995;36(4):672–84.PubMedCrossRef Mauriège P, Marette A, Atgié C, Bouchard C, Thériault G, Bukowiecki LK, et al. Regional variation in adipose tissue metabolism of severely obese premenopausal women. J Lipid Res. 1995;36(4):672–84.PubMedCrossRef
31.
go back to reference Stern JH, Rutkowski JM, Scherer PE. Adiponectin, Leptin, and fatty acids in the Maintenance of Metabolic Homeostasis through adipose tissue crosstalk. Cell Metab. 2016;23(5):770–84.PubMedPubMedCentralCrossRef Stern JH, Rutkowski JM, Scherer PE. Adiponectin, Leptin, and fatty acids in the Maintenance of Metabolic Homeostasis through adipose tissue crosstalk. Cell Metab. 2016;23(5):770–84.PubMedPubMedCentralCrossRef
32.
go back to reference Bays HE. Adiposopathy is sick fat a cardiovascular disease? J Am Coll Cardiol. 2011;57(25):2461–73.PubMedCrossRef Bays HE. Adiposopathy is sick fat a cardiovascular disease? J Am Coll Cardiol. 2011;57(25):2461–73.PubMedCrossRef
33.
go back to reference Inoue M, Maehata E, Yano M, Taniyama M, Suzuki S. Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes. Metabolism. 2005;54(3):281–6.PubMedCrossRef Inoue M, Maehata E, Yano M, Taniyama M, Suzuki S. Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes. Metabolism. 2005;54(3):281–6.PubMedCrossRef
34.
go back to reference Edens NK, Fried SK, Kral JG, Hirsch J, Leibel RL. In vitro lipid synthesis in human adipose tissue from three abdominal sites. Am J Physiol. 1993;265(3 Pt 1):E374–9.PubMed Edens NK, Fried SK, Kral JG, Hirsch J, Leibel RL. In vitro lipid synthesis in human adipose tissue from three abdominal sites. Am J Physiol. 1993;265(3 Pt 1):E374–9.PubMed
35.
go back to reference Farnier C, Krief S, Blache M, Diot-Dupuy F, Mory G, Ferre P, et al. Adipocyte functions are modulated by cell size change: potential involvement of an integrin/ERK signalling pathway. Int J Obes Relat Metab Disord. 2003;27(10):1178–86.PubMedCrossRef Farnier C, Krief S, Blache M, Diot-Dupuy F, Mory G, Ferre P, et al. Adipocyte functions are modulated by cell size change: potential involvement of an integrin/ERK signalling pathway. Int J Obes Relat Metab Disord. 2003;27(10):1178–86.PubMedCrossRef
37.
go back to reference Wedellova Z, Dietrich J, Siklova-Vitkova M, Kolostova K, Kovacikova M, Duskova M, et al. Adiponectin inhibits spontaneous and catecholamine-induced lipolysis in human adipocytes of non-obese subjects through AMPK-dependent mechanisms. Physiol Res. 2011;60(1):139–48.PubMedCrossRef Wedellova Z, Dietrich J, Siklova-Vitkova M, Kolostova K, Kovacikova M, Duskova M, et al. Adiponectin inhibits spontaneous and catecholamine-induced lipolysis in human adipocytes of non-obese subjects through AMPK-dependent mechanisms. Physiol Res. 2011;60(1):139–48.PubMedCrossRef
38.
go back to reference Arner P, Marcus C, Karpe B, Sonnenfeld T, Blome P. Role of alpha-adrenoceptors for adipocyte size in man. Eur J Clin Invest. 1987;17(1):58–62.PubMedCrossRef Arner P, Marcus C, Karpe B, Sonnenfeld T, Blome P. Role of alpha-adrenoceptors for adipocyte size in man. Eur J Clin Invest. 1987;17(1):58–62.PubMedCrossRef
39.
go back to reference Pico C, Palou M, Pomar CA, Rodriguez AM, Palou A. Leptin as a key regulator of the adipose organ. Rev Endocr Metab Disord. 2022;23(1):13–30.PubMedCrossRef Pico C, Palou M, Pomar CA, Rodriguez AM, Palou A. Leptin as a key regulator of the adipose organ. Rev Endocr Metab Disord. 2022;23(1):13–30.PubMedCrossRef
40.
go back to reference Fried SK, Leibel RL, Edens NK, Kral JG. Lipolysis in intraabdominal adipose tissues of obese women and men. Obes Res. 1993;1(6):443–8.PubMedCrossRef Fried SK, Leibel RL, Edens NK, Kral JG. Lipolysis in intraabdominal adipose tissues of obese women and men. Obes Res. 1993;1(6):443–8.PubMedCrossRef
41.
go back to reference Drolet R, Richard C, Sniderman AD, Mailloux J, Fortier M, Huot C, et al. Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int J Obes (Lond). 2008;32(2):283–91.PubMedCrossRef Drolet R, Richard C, Sniderman AD, Mailloux J, Fortier M, Huot C, et al. Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int J Obes (Lond). 2008;32(2):283–91.PubMedCrossRef
42.
go back to reference Ramis JM, Bibiloni B, Moreiro J, Garcia-Sanz JM, Salinas R, Proenza AM, et al. Tissue leptin and plasma insulin are associated with lipoprotein lipase activity in severely obese patients. J Nutr Biochem. 2005;16(5):279–85.PubMedCrossRef Ramis JM, Bibiloni B, Moreiro J, Garcia-Sanz JM, Salinas R, Proenza AM, et al. Tissue leptin and plasma insulin are associated with lipoprotein lipase activity in severely obese patients. J Nutr Biochem. 2005;16(5):279–85.PubMedCrossRef
43.
go back to reference Giusti V, Suter M, Verdumo C, Gaillard RC, Burckhardt P, Pralong FP. Molecular determinants of human adipose tissue: differences between visceral and subcutaneous compartments in obese women. J Clin Endocrinol Metab. 2004;89(3):1379–84.PubMedCrossRef Giusti V, Suter M, Verdumo C, Gaillard RC, Burckhardt P, Pralong FP. Molecular determinants of human adipose tissue: differences between visceral and subcutaneous compartments in obese women. J Clin Endocrinol Metab. 2004;89(3):1379–84.PubMedCrossRef
44.
go back to reference Mauriège P, Joanisse DR, CasparBauguil S, Cartier A, Lemieux I, Bergeron J, et al. Gene expression of different adipose tissues of severely obese women with or without a dysmetabolic profile. J Physiol Biochem. 2015;71(4):719–32.PubMedCrossRef Mauriège P, Joanisse DR, CasparBauguil S, Cartier A, Lemieux I, Bergeron J, et al. Gene expression of different adipose tissues of severely obese women with or without a dysmetabolic profile. J Physiol Biochem. 2015;71(4):719–32.PubMedCrossRef
45.
go back to reference Lefebvre AM, Laville M, Vega N, Riou JP, van Gaal L, Auwerx J, et al. Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes. 1998;47(1):98–103.PubMedCrossRef Lefebvre AM, Laville M, Vega N, Riou JP, van Gaal L, Auwerx J, et al. Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes. 1998;47(1):98–103.PubMedCrossRef
46.
go back to reference Veilleux A, Blouin K, Rhéaume C, Daris M, Marette A, Tchernof A. Glucose transporter 4 and insulin receptor substrate-1 messenger RNA expression in omental and subcutaneous adipose tissue in women. Metabolism. 2009;58(5):624–31.PubMedCrossRef Veilleux A, Blouin K, Rhéaume C, Daris M, Marette A, Tchernof A. Glucose transporter 4 and insulin receptor substrate-1 messenger RNA expression in omental and subcutaneous adipose tissue in women. Metabolism. 2009;58(5):624–31.PubMedCrossRef
47.
go back to reference Marette A, Mauriège P, Marcotte B, Atgié C, Bouchard C, Thériault G, et al. Regional variation in adipose tissue insulin action and GLUT4 glucose transporter expression in severely obese premenopausal women. Diabetologia. 1997;40(5):590–8.PubMedCrossRef Marette A, Mauriège P, Marcotte B, Atgié C, Bouchard C, Thériault G, et al. Regional variation in adipose tissue insulin action and GLUT4 glucose transporter expression in severely obese premenopausal women. Diabetologia. 1997;40(5):590–8.PubMedCrossRef
48.
go back to reference Laforest S, Michaud A, Paris G, Pelletier M, Vidal H, Geloen A, et al. Comparative analysis of three human adipocyte size measurement methods and their relevance for cardiometabolic risk. Obes (Silver Spring). 2017;25(1):122–31.CrossRef Laforest S, Michaud A, Paris G, Pelletier M, Vidal H, Geloen A, et al. Comparative analysis of three human adipocyte size measurement methods and their relevance for cardiometabolic risk. Obes (Silver Spring). 2017;25(1):122–31.CrossRef
49.
go back to reference Mauriège P, Galitzky J, Berlan M, Lafontan M. Heterogeneous distribution of beta and alpha-2 adrenoceptor binding sites in human fat cells from various fat deposits: functional consequences. Eur J Clin Invest. 1987;17(2):156–65.PubMedCrossRef Mauriège P, Galitzky J, Berlan M, Lafontan M. Heterogeneous distribution of beta and alpha-2 adrenoceptor binding sites in human fat cells from various fat deposits: functional consequences. Eur J Clin Invest. 1987;17(2):156–65.PubMedCrossRef
50.
go back to reference Hellmer J, Marcus C, Sonnenfeld T, Arner P. Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells. J Clin Endocrinol Metab. 1992;75(1):15–20.PubMed Hellmer J, Marcus C, Sonnenfeld T, Arner P. Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells. J Clin Endocrinol Metab. 1992;75(1):15–20.PubMed
51.
go back to reference Vogel C, Marcotte EM. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet. 2012;13(4):227–32.PubMedPubMedCentralCrossRef Vogel C, Marcotte EM. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet. 2012;13(4):227–32.PubMedPubMedCentralCrossRef
52.
go back to reference Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology. 2004;145(5):2273–82.PubMedCrossRef Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology. 2004;145(5):2273–82.PubMedCrossRef
Metadata
Title
Plasma adiponectin/leptin ratio associates with subcutaneous abdominal and omental adipose tissue characteristics in women
Authors
Eve-Julie Tremblay
André Tchernof
Mélissa Pelletier
Denis R. Joanisse
Pascale Mauriège
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2024
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-024-01567-8

Other articles of this Issue 1/2024

BMC Endocrine Disorders 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.